Publications by authors named "Claude Meric"

Claim this Profile
P
Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety.
Emmanuel Feroldi, Chitsanu Pancharoen, Pope Kosalaraksa, Kulkanya Chokephaibulkit, Mark Boaz, Claude Meric

Pediatr Infect Dis J· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India.
Matthew Bonaparte, Bashir Dweik, Emmanuel Feroldi, Claude Meric, Alain Bouckenooghe

BMC Infect Dis· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children.
Emmanuel Feroldi, Maria Rosario Capeding, Mark Boaz, Sophia Gailhardou, Claude Meric

Hum Vaccin Immunother· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: randomized, double-blind, 5-year phase II study in healthy adults.
Peter E Nasveld, Andrew Ebringer, Nathan Elmes, Sonya Bennett, Sutee Yoksan, Claude Meric

Hum Vaccin· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials.
Joseph Torresi, Karen McCarthy, Emmanuel Feroldi, Claude Méric

Vaccine· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV-seronegative subjects.
Mark R Schleiss, David I Bernstein, Murray Passo, Susan Parker, Claude Meric

Vaccine· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults.
David I Bernstein, Mark R Schleiss, Klara Berencsi, Eva Gonczol, Michelle Dickey, Claude Meric

J Infect Dis· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis